This archive contains the following articles listed by volume, issue and page number:
 |
|
|
Volume 10, 2006 Articles |
Title (Click for Details) |
Vol/Issue |
Page |
PreScription: A Decade of IJPC |
Vol. 10 No. 1 |
2 |
CompoundingToday.com: Literature, Book Reviews, & More |
Vol. 10 No. 1 |
5 |
Compounding Pharmacy: The Past Decade |
Vol. 10 No. 1 |
6 |
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh |
Vol. 10 No. 1 |
9 |
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery |
Vol. 10 No. 1 |
14 |
Pharmaceutical Legislation: An Historical Perspective |
Vol. 10 No. 1 |
20 |
Pharmacy Compounding Urban Legends |
Vol. 10 No. 1 |
32 |
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations |
Vol. 10 No. 1 |
36 |
Quality Control Analytical Methods: Common Concerns about Out-of-Specification Results |
Vol. 10 No. 1 |
41 |
Acacia and Mineral Oil Emulsion NF |
Vol. 10 No. 1 |
44 |
How'd They Do That? |
Vol. 10 No. 1 |
46 |
Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success |
Vol. 10 No. 1 |
50 |
Standard Operating Procedure: Shipping of Prescriptions |
Vol. 10 No. 1 |
56 |
Calculations |
Vol. 10 No. 1 |
58 |
Chlorambucil 2-mg/mL Oral Liquid |
Vol. 10 No. 1 |
59 |
Dantrolene Sodium 5-mg/mL Oral Liquid |
Vol. 10 No. 1 |
60 |
Domperidone 1-mg/mL Oral Liquid |
Vol. 10 No. 1 |
61 |
Efavirenz 20-mg/mL Oral Liquid, Anhydrous |
Vol. 10 No. 1 |
62 |
Medium-Chain Triglycerides Oral Vehicle, Anhydrous |
Vol. 10 No. 1 |
63 |
Mercaptopurine 50-mg/mL Oral Liquid |
Vol. 10 No. 1 |
64 |
Misoprostol 1-mg Suppository |
Vol. 10 No. 1 |
65 |
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid |
Vol. 10 No. 1 |
66 |
Propylthiouracil 5-mg/mL Oral Liquid |
Vol. 10 No. 1 |
67 |
Thioguanine 40-mg/mL Oral Liquid |
Vol. 10 No. 1 |
68 |
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management |
Vol. 10 No. 1 |
69 |
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds |
Vol. 10 No. 1 |
74 |
Scientific and Professional Reviewers for 2005 |
Vol. 10 No. 1 |
79 |
PostScription: Stopping Drug Reps at the Door |
Vol. 10 No. 1 |
80 |
PreScription: The Squeaky Wheel Gets the Grease! |
Vol. 10 No. 2 |
82 |
Erratum: Allen LV Jr. Lidocaine hydrochloride 2%, misoprostol 0.0024%, and phenytoin 2% topical wound powder. IJPC 2004; 8(4): 298 |
Vol. 10 No. 2 |
82 |
Compounding Pharmacy: The Past Decade, Part 2 -- Equipment Advances |
Vol. 10 No. 2 |
86 |
Hospice from a Compounding Pharmacist's Perspective |
Vol. 10 No. 2 |
89 |
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient |
Vol. 10 No. 2 |
95 |
The Story of Hospice |
Vol. 10 No. 2 |
100 |
The Dying Process |
Vol. 10 No. 2 |
103 |
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives |
Vol. 10 No. 2 |
107 |
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist |
Vol. 10 No. 2 |
113 |
Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations |
Vol. 10 No. 2 |
122 |
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1 |
Vol. 10 No. 2 |
128 |
Standard Operating Procedure: Labconco Basic 47 Laboratory Hood |
Vol. 10 No. 2 |
135 |
Calculations |
Vol. 10 No. 2 |
136 |
Amlodipine 1-mg/mL Oral Liquid |
Vol. 10 No. 2 |
137 |
Chloroquine Phosphate 15-mg/mL Oral Liquid |
Vol. 10 No. 2 |
138 |
Cimetidine 60-mg/mL Oral Liquid, Alcohol Free |
Vol. 10 No. 2 |
139 |
Disopyramide Phosphate 1-mg/mL Oral Liquid |
Vol. 10 No. 2 |
140 |
Mycophenolate Mofetil 50-mg/mL Oral Liquid |
Vol. 10 No. 2 |
141 |
Norfloxacin 20-mg/mL Oral Liquid |
Vol. 10 No. 2 |
142 |
Saquinavir 60-mg/mL Oral Liquid |
Vol. 10 No. 2 |
143 |
Sotalol Hydrochloride 5-mg/mL Oral Liquid |
Vol. 10 No. 2 |
144 |
Terbinafine Hydrochloride 25-mg/mL Oral Liquid |
Vol. 10 No. 2 |
145 |
Trazodone Hydrochloride 10-mg/mL Oral Liquid |
Vol. 10 No. 2 |
146 |
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis |
Vol. 10 No. 2 |
147 |
Chemical Stability of Diclofenac Sodium Injection |
Vol. 10 No. 2 |
154 |
Extended Stability of Oxytocin in Common Infusion Solutions |
Vol. 10 No. 2 |
156 |
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol |
Vol. 10 No. 2 |
159 |
PreScription: Standards, Legal Standards, and Accreditation |
Vol. 10 No. 3 |
162 |
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate |
Vol. 10 No. 3 |
165 |
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor |
Vol. 10 No. 3 |
172 |
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States |
Vol. 10 No. 3 |
175 |
Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update |
Vol. 10 No. 3 |
187 |
Probiotic Therapy, Part 2: Clinical Perspectives |
Vol. 10 No. 3 |
195 |
Quick Tips for Managing Market Directors |
Vol. 10 No. 3 |
201 |
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? |
Vol. 10 No. 3 |
202 |
Basics of Compounding for Dentistry, Part 2: Tooth Whitening |
Vol. 10 No. 3 |
205 |
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 |
Vol. 10 No. 3 |
208 |
Wise Buys: Choosing the Right Software for a Compounding Pharmacy |
Vol. 10 No. 3 |
213 |
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions |
Vol. 10 No. 3 |
218 |
Calculations |
Vol. 10 No. 3 |
219 |
Carvedilol 1.25-mg/mL Oral Suspension |
Vol. 10 No. 3 |
220 |
Enalapril Maleate 1-mg/mL Oral Suspension |
Vol. 10 No. 3 |
221 |
Granisetron 0.05-mg/mL Oral Suspension |
Vol. 10 No. 3 |
222 |
Lamotrigine 1-mg/mL Oral Suspension |
Vol. 10 No. 3 |
223 |
Mesna 20-mg/mL Syrup |
Vol. 10 No. 3 |
224 |
Mexiletine Hydrochloride 10-mg/mL Oral Suspension |
Vol. 10 No. 3 |
225 |
Pyrimethamine 2-mg/mL Oral Suspension |
Vol. 10 No. 3 |
226 |
Quinapril 1-mg/mL Oral Liquid |
Vol. 10 No. 3 |
227 |
Theophylline 5-mg/mL Oral Liquid, Alcohol-Free |
Vol. 10 No. 3 |
228 |
Triamcinolone Acetonide 0.1% Mouthwash Solution |
Vol. 10 No. 3 |
229 |
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration |
Vol. 10 No. 3 |
230 |
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration |
Vol. 10 No. 3 |
234 |
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together |
Vol. 10 No. 3 |
237 |
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! |
Vol. 10 No. 3 |
240 |
PreScription: 6-Year or 7-Year Program? |
Vol. 10 No. 4 |
242 |
Introduction to Hospital Compounding |
Vol. 10 No. 4 |
245 |
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations |
Vol. 10 No. 4 |
253 |
Putting the Science Back into the "Art and Science" of Compounding |
Vol. 10 No. 4 |
263 |
Compounded Treatment Options for Cystitis and Other Bladder Problems |
Vol. 10 No. 4 |
270 |
Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces |
Vol. 10 No. 4 |
277 |
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist |
Vol. 10 No. 4 |
281 |
What are You Willing to Do? |
Vol. 10 No. 4 |
287 |
Hospice Symptom Relief Kit: An Update |
Vol. 10 No. 4 |
288 |
Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight |
Vol. 10 No. 4 |
291 |
Aseptic Compounding in New Zealand and the Use of Still Air Boxes |
Vol. 10 No. 4 |
293 |
Standard Operating Procedure: Testing of Water Supply: Barnstead D4751 High Purity Water System |
Vol. 10 No. 4 |
296 |
Calculations |
Vol. 10 No. 4 |
298 |
Adderall 1-mg/mL Oral Liquid |
Vol. 10 No. 4 |
299 |
Dapsone 2-mg/mL Oral Liquid |
Vol. 10 No. 4 |
300 |
Itraconazole 40-mg/mL Oral Liquid |
Vol. 10 No. 4 |
301 |
Lisinopril 1-mg/mL Oral Liquid |
Vol. 10 No. 4 |
302 |
Nifedipine 4-mg/mL Oral Liquid |
Vol. 10 No. 4 |
303 |
Propranolol Hydrochloride 1-mg/mL Oral Liquid |
Vol. 10 No. 4 |
304 |
Rifabutin 20-mg/mL Oral Liquid |
Vol. 10 No. 4 |
305 |
Sildenafil Citrate 2.5-mg/mL Oral Liquid |
Vol. 10 No. 4 |
306 |
Tramadol Hydrochloride 5-mg/mL Oral Liquid |
Vol. 10 No. 4 |
307 |
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid |
Vol. 10 No. 4 |
308 |
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729> |
Vol. 10 No. 4 |
309 |
Stability of Memantine in an Extemporaneously Prepared Oral Liquid |
Vol. 10 No. 4 |
316 |
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free |
Vol. 10 No. 4 |
318 |
PostScription: Patients or Clients? |
Vol. 10 No. 4 |
320 |
PreScription: Certification and Accreditation |
Vol. 10 No. 5 |
322 |
Topical Cidofovir for Treatment of Resistant Viral Infections |
Vol. 10 No. 5 |
324 |
Mesotherapy: Cosmetic Applications |
Vol. 10 No. 5 |
331 |
Dermatological Effects from Years in the Sun: Compounding Opportunities |
Vol. 10 No. 5 |
336 |
Migraine: A General Approach to Prevention and Treatment |
Vol. 10 No. 5 |
344 |
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches |
Vol. 10 No. 5 |
351 |
University of North Carolina at Chapel Hill School of Pharmacy Pharmaceutical Care Laboratories: Compounding Laboratory Curriculum and Renovation |
Vol. 10 No. 5 |
353 |
Education, Training, and Evaluation of Hospital Compounding Personnel |
Vol. 10 No. 5 |
361 |
MEDLINE: A Valuable Research Tool for the Compounding Pharmacist |
Vol. 10 No. 5 |
369 |
Quality-Control Analytical Methods: Sterility Failure Investigations |
Vol. 10 No. 5 |
372 |
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction |
Vol. 10 No. 5 |
377 |
Calculations |
Vol. 10 No. 5 |
380 |
Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations |
Vol. 10 No. 5 |
381 |
Famotidine 8-mg/mL Oral Liquid |
Vol. 10 No. 5 |
382 |
Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration |
Vol. 10 No. 5 |
383 |
Hydroxyurea 100 mg/mL |
Vol. 10 No. 5 |
384 |
Indinavir 10-mg/mL Oral Liquid |
Vol. 10 No. 5 |
385 |
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid |
Vol. 10 No. 5 |
386 |
Midazolam Hydrochloride 1-mg/mL Oral Liquid |
Vol. 10 No. 5 |
387 |
Nitrazepam 1-mg/mL Oral Liquid |
Vol. 10 No. 5 |
388 |
Omeprazole 2-mg/mL Oral Liquid |
Vol. 10 No. 5 |
389 |
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) |
Vol. 10 No. 5 |
390 |
Pantoprazole Sodium 2-mg/mL Oral Liquid |
Vol. 10 No. 5 |
391 |
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel |
Vol. 10 No. 5 |
392 |
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions |
Vol. 10 No. 5 |
396 |
PostScription: Moving Pharmacy Compounding into the 21st Century and Beyond |
Vol. 10 No. 5 |
400 |
PreScription: International Journal of Pharmaceutical Compounding is Expanding |
Vol. 10 No. 6 |
402 |
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals |
Vol. 10 No. 6 |
405 |
Compounding for Feline Herpetic Keratitis |
Vol. 10 No. 6 |
411 |
Compounding for Veterinary Medicine |
Vol. 10 No. 6 |
417 |
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety |
Vol. 10 No. 6 |
418 |
Taurine for the Treatment of Canine Dilated Cardiomyopathy |
Vol. 10 No. 6 |
421 |
Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard) |
Vol. 10 No. 6 |
426 |
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle |
Vol. 10 No. 6 |
428 |
Ronidazole in the Treatment of Trichomonad Infections in Cats |
Vol. 10 No. 6 |
434 |
Equipment, Supplies, and Facilities Required for Hospital Compounding |
Vol. 10 No. 6 |
436 |
Quality Control Analytical Methods: Continuous Quality Improvement |
Vol. 10 No. 6 |
442 |
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination |
Vol. 10 No. 6 |
446 |
Calculations: Compounding for Large and Small Animals |
Vol. 10 No. 6 |
449 |
Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies |
Vol. 10 No. 6 |
450 |
Amiloride Hydrochloride 1-mg/mL Oral Liquid |
Vol. 10 No. 6 |
452 |
Chloral Hydrate 50-mg/mL Oral Liquid |
Vol. 10 No. 6 |
453 |
Cyclophosphamide 2-mg/mL Oral Liquid |
Vol. 10 No. 6 |
454 |
Disulfiram 25-mg/mL Oral Liquid |
Vol. 10 No. 6 |
455 |
Gabapentin 100-mg/mL Oral Liquid |
Vol. 10 No. 6 |
456 |
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid |
Vol. 10 No. 6 |
457 |
Indomethacin 2-mg/mL Oral Liquid |
Vol. 10 No. 6 |
458 |
Naltrexone 1-mg/mL Oral Liquid |
Vol. 10 No. 6 |
459 |
Terbutaline Sulfate 1-mg/mL Oral Liquid |
Vol. 10 No. 6 |
460 |
Valacyclovir 50-mg/mL Oral Liquid |
Vol. 10 No. 6 |
461 |
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists |
Vol. 10 No. 6 |
462 |
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations |
Vol. 10 No. 6 |
469 |
PostScription: Challenges Facing an Analytical Laboratory |
Vol. 10 No. 6 |
479 |